<DOC>
	<DOC>NCT01808911</DOC>
	<brief_summary>CREHA project is a study comparing steroid combined with cyclophosphamide versus steroid combined with rituximab in patients with acquired haemophilia. The study will test the hypothesis that steroid combined with cyclophosphamide is more effective than steroid plus rituximab for FVIII inhibitor eradication in acquired haemophilia.</brief_summary>
	<brief_title>Outcome of Acquired Haemophilia With Steroid Combined With Cyclophosphamide Versus Steroid Combined With Rituximab (CREHA Study)</brief_title>
	<detailed_description>CREHA project is a multicenter, randomized, controlled efficacity and safety study comparing steroid combined with cyclophosphamide versus steroid combined with rituximab in patients with acquired haemophilia. The study will test the hypothesis that steroid combined with cyclophosphamide is more effective than steroid plus rituximab for FVIII inhibitor eradication in acquired haemophilia</detailed_description>
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<criteria>men or women women postmenpausal or with ongoing contraception 18 years old or more diagnosis of acquired hemophilia patient must be insured patient has provided written informed consent prior to enrolment patient compliant constitutional hemophilia chemotherapy ongoing treatment with prednisone &gt; 20mg further more 1 month ongoing treatment with prednisone &gt;0.7 mg/d further more 10 days thrombocytopenia leukopenia chronic disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Acquired haemophilia</keyword>
	<keyword>Comparative and randomized study</keyword>
	<keyword>Cyclophosphamide</keyword>
	<keyword>Rituximab</keyword>
</DOC>